Advertisement

BMC Infectious Diseases

, 19:420 | Cite as

Epidemiology of urinary tract infection and antimicrobial resistance in a pediatric hospital in Nepal

  • Rabina Ganesh
  • Dhiraj ShresthaEmail author
  • Balkrishna Bhattachan
  • Ganesh Rai
Open Access
Research article
  • 248 Downloads
Part of the following topical collections:
  1. Bacterial and fungal diseases

Abstract

Background

Urinary tract infection is an infection affecting infants and children. The aim of this study was to determine the etiology of urinary tract infection along with their antimicrobial resistance.

Methods

This cross-sectional study was conducted from June 2015 to January 2016 at Siddhi Memorial Hospital, Bhaktapur, Nepal. Urine samples were first cultured on cystine lactose electrolyte deficient agar and blood agar by semi-quantitative technique, and then incubated aerobically for 18–24 h at 37 °C. The identified bacterial isolates were tested for antimicrobial susceptibility by Kirby Bauer disc diffusion technique.

Results

Of 1599 urine samples, 12.3% samples showed significant bacterial growth. E. coli (58.7%) was the most common pathogen, followed by Klebsiella pneumoniae (22.5%). Most of the isolates were resistant to ampicillin and co-trimoxazole, while least were resistant to amikacin and nitrofurantoin. Higher multi-drug resistance (61.9%) was observed among isolates.

Conclusions

E. coli and Klebsiella spp. were predominant cause of pediatric urinary tract infection in children. Higher susceptibility observed against aminoglycosides and nitrofurans make these drugs suitable in emergency.

Keywords

Antimicrobial resistance E. coli Klebsiella spp. Nepal Urinary tract infection 

Abbreviations

AMR

Antimicrobial resistance

ATCC

American type culture collection

CFU

Colony forming unit

CLSI

Clinical Laboratory Standard Institute

MDR

Multidrug resistant

UTI

Urinary tract infection

Background

Urinary tract infection (UTI) is any infection leading to an inflammatory response in the epithelium of the urinary tract [1]. UTIs affect both males and females of all ages. The occurrences of UTIs are higher in women, which are likely caused by anatomical differences, hormonal effects and behaviors [2]. The cases of UTI among Nepalese patients attending general hospitals ranges from 23.1 to 37.4% [3]. Bacteria are the common etiology of UTIs accounting more than 95% of the cases. Escherichia coli is the most common causative organisms of UTI and is solely responsible for more than 80% of UTI [4].

This study was conducted among children with symptoms of UTI visiting a tertiary healthcare in Nepal to determine spectra of uropathogens, especially E. coli and Klebsiella spp., and their antimicrobial resistance (AMR). This would help the clinician in using appropriate antibiotics for the clinical management of UTI.

Methods

Study design, area and sample population

The cross-sectional study was conducted from June 2015 to January 2016 in Siddhi Memorial Hospital, Bhaktapur, Nepal. The Hospital is the only children hospital in the district and serves infants and children patients of the district and other nearby areas. The totals of 1599 urine samples were included in this study. The study populations were infants and children patients not exceeding 14 years age, seeking treatment at the hospital with symptoms of UTI. The symptoms included fever along with dysuria and/or loss of bladder control and/or lower back pain and/or cloudy or foul smelling urine. For infants and younger children symptoms included was fever and parental reporting of cloudy or foul smelling urine. The clean catch urine samples were collected in sterile container. In infants and non-toilet-trained children, a sterile foil bowl was placed underneath the genitalia for clean-catch urine collection. If this was not possible, a plastic bag was attached to genitalia for urine collection. In toilet-trained children, a clean-catch voided midstream urine sample was collected. In both cases the genitalia was cleaned beforehand to reduce contamination. Invasive techniques were avoided for urine collection. Children receiving antimicrobial drugs treatment and children undergoing bladder catheterization within 48 h were excluded in the study. The study was ethically approved by the Institutional Review Committee of Shi-Gan International College of Science and Technology (SICOST).

Laboratory examinations of samples

Macroscopic examination of urine

Urine color was observed macroscopically immediately after collection for possible signs of contaminations.

Processing of samples and identification of the isolates

First of all, 1 μL of all urine samples were streaked on cystine lactose electrolyte deficient (CLED) agar (HiMedia Pvt. Ltd., India) and blood agar (HiMedia Pvt. Ltd., India) by semi-quantitative method using calibrated loop. The plates were then incubated aerobically for 18–48 h at 37 °C and growths were observed. Positive culture result was considered for plates showing 100 or more colonies i.e. more than or equal to 105 colony forming units (CFU)/ml [5]. Identifications of isolates were done considering Gram’s staining morphology, cultural characteristics and biochemical properties [6].

Antimicrobial susceptibility testing

All identified isolates of E. coli and Klebsiella spp. were tested for susceptibility against amikacin (30 μg), ampicillin (10 μg), cephalexin (30 μg), cefixime (10 μg), cefpodoxime (30 μg), co-trimoxazole (1.25/23.75 μg), nitrofurantoin (300 μg), ofloxacin (5 μg) (HiMedia Pvt. Ltd., India) using Kirby Bauer disc diffusion technique on Mueller-Hinton agar (HiMedia Pvt. Ltd., India). The results were interpreted using CLSI 2015 [7]. Quality control was accessed using E. coli ATCC 25922. Isolates resisting two or more classes of antimicrobial agents were considered multidrug resistant (MDR) [8].

Data management and statistical analysis

Data obtained were entered and managed in Microsoft Excel (version 2010, Microsoft Corporation, USA), and relation of variables were analyzed using ratio and percentage.

Results

Among total 1599 urine samples processed, 929 (58.1%) samples were collected from male children while 668 (41.8%) samples from female children. Of 1599 samples, only 197 (12.3%) samples were culture positive and hence UTI. Of 197 UTI cases, UTIs were higher in female children, i.e. 120 (60.9%) compared to male children, i.e. 77 (39.1%). UTIs were highest in age group 2–5 years (Table 1).
Table 1

Gender and age distribution of UTIs among children

Age group (years)

Male (%)

Female (%)

Total

≤1

24 (43.6)

31 (56.3)

55

2–5

33 (36.6)

57 (63.3)

90

6–9

17 (41.4)

24 (58.5)

41

10–14

3 (27.2)

8 (72.7)

11

Total

77 (39.1)

120 (60.9)

197

Rate of UTIs in inpatients and outpatients were similar (Table 2).
Table 2

Distribution of UTIs in children

Types of patient

Total patients

UTI positive

%

Inpatient

159

20

12.6

Outpatient

1440

177

12.3

Total

1599

197

12.3

Total of seven different species of Gram negative bacteria were isolated. Among them, E. coli, 114 (57.8%) was predominant followed by Klebsiella spp., 62 (31.4%) (Fig. 1).
Fig. 1

Identified bacterial isolates in UTI patients (%). Legends (as represented by different colors in pie diagram): Each color represent the fraction of the total isolated bacteria in percentage namely, Ec = E. coli, Kp = K. pneumoniae, Ko = K. oxytoca, Pm = P. mirabilis, Pv = P. vulgaris, Cf = C. freundii, Ps = Pseudomonas spp., Sa = S. aureus, En = Enterococcus spp.

Most K. oxytoca isolates were resistant to cephalexin, 16 (94.1%) and least were resistant to nitrofurantoin, 4 (23.5%) and amikacin, 4 (23.5%). Likewise, most K. pneumoniae isolates were resistant to ampicillin, 35 (77.8%) and least were resistant to amikacin, 4 (8.9) (Fig. 2). Most E. coli isolates were resistant to ampicillin, 82 (71.9%) and least were resistant to nitrofurantoin, 5 (4.4%) (Fig. 3). Higher score of MDR, 109 (61.9%), was observed among isolates (Table 3).
Fig. 2

Antibiotic resistivity of K. pneumoniae and K. oxytoca. Legends (as represented by two colors): Red color represents the resistivity percentage of K. oxytoca against the antibiotics. Blue color represents the resistivity percentage of K. pneumoniae against the antibiotics

Fig. 3

Antibiotic resistivity of E. coli. Legends (as represented by red color): Red color represents the resistivity percentage of E. coli against the antibiotics

Table 3

MDR among isolates

Bacteria

Total isolates

MDR isolates (%)

E. coli

114

72 (63.2)

Klebsiella pneumoniae

45

26 (57.8)

K. oxytoca

17

11 (64.7)

Total

176

109 (61.9)

Discussion

UTIs are frequent in children and may incur adverse consequences [9]. Thus, reliable diagnosis of UTI in children is critical. In our study, only 12.3% of the 1599 urine samples yielded culture positive result. This warrants discordance of clinical and laboratory examination in the hospital. Laboratories choose one diagnostic threshold but there is no universally accepted threshold. We used the threshold of 105 CFU/ml to determine culture positive result. This can miss lower bacterial counts. Higher threshold could have decreased the culture positive result. Lowering the threshold to 104 CFU/ml can produce clinically valuable results [10].

The study population had higher male children compared to female children (male to female ratio 3:2). This was the involuntary recruitment bias. The other bias could be greater parental urge and/or greater doctors’ preference in testing male children than female children. Also, this could be due to greater difficulty in clinically diagnosing male UTI. On contrast, UTIs were higher in female children as compared to male children (female to male ratio = 3:2). UTIs are more common in girls compared to boys due to shorter length of urethra [11]. Also, this could be due to better clinical diagnosis of UTI in girls than boys by doctors. Or this could be due to more likelihood of growth from specimens collected from females, perhaps due to higher rates of contamination of male specimens. This concords with other reports [3, 4, 9, 12]. With the increase in age, female children showed considerable increase in UTI compared to male children. Majority of UTIs were seen in the ages below 6 years of age. Likewise, rate of UTIs was fairly similar in outpatients and inpatients.

Among seven identified Gram negative bacterial species, E. coli (57.8%), was the predominant followed by Klebsiella spp. (31.4%). This concords with other studies [3, 4, 9, 12, 13]. E. coli and K. pneumoniae have emerged as serious pathogens worldwide. UTI occurs when E. coli and/or other gastrointestinal tract flora enters urinary tract [14].

Antibiotics play crucial role in treating such infections as long as the etiological bacteria is susceptible to the antibiotic activity. Thus, determining accurate antibiotic susceptibility is essential in the clinical care of bacterial infections. Bacteria capable of acquiring resistance demands more attention [15]. Most scholars throughout the world are reporting increasing AMR.

Most children are treated empirically before laboratory findings to avoid complications [9]. Both E. coli and Klebsiella spp. showed high resistance to ampicillin. This concord with other studies [3, 4, 9, 12, 13]. Susceptibility of E. coli and K. pneumoniae against different cephalosporins was similar. About 60% isolates were resistance to cephalosporins thus cephalosporins can be treatment option but cannot be relied as reserve drug or empiric drug. But higher generations of cephalosporins could promise effectiveness as shown by lower resistance against cefotaxime, about 40%. In contrast, K. oxytoca showed higher resistance to cephalosporins rendering ineffective for treatment. This further makes cephalosporins antibiotics unlikely for use as reserve 2nd line drug for treatment. Co-trimoxazole is preferred oral antibiotic for treatment of pediatric UTI but only half of the E. coli and Klebsiella spp. isolates were susceptible. Thus, sulfonamide antibiotics cannot be relied solely for treatment. Ofloxacin was ineffective against half of the E. coli isolates and one-fifth of Klebsiella spp. isolates. This makes fluoroquinolones antibiotics unreliable 2nd line choice as well. Meanwhile, nitrofurantoin and amikacin were effective against most of the E. coli and Klebsiella spp. isolates. Thus, nitrofurans antibiotics can be relied as 1st line choice for empiric treatment. Nitrofurans is also the economical option as it is comparatively cheaper. Alternatively, aminoglycosides antibiotics can also serve as reasonable choice. These drugs can thus be reserved for emergency use. Higher score of MDR (61.9%) among isolates underlines the higher risks associated with AMR and ask serious counter measures.

Inappropriate policies, poor surveillance, self-medication, poor diagnosis, poor quality of antibiotics, inadequate dose has all attributed to increase in AMR in recent years [16]. Inappropriate use of antibiotics in healthcare has increased the risk of AMR growth. This study was limited to phenotypic AMR detection excluding identification of different beta-lactamases producing bacteria. Genotyping characterization would provide further insight on AMR.

Conclusions

Our findings outline high AMR among common uropathogens in tertiary setting. Varying epidemiology of AMR with time and locales has hindered the effective management of infections. Since, our study was confined to single healthcare setting, only the broader and effective surveillance can establish AMR data for effective clinical management of such pathogens. Such AMR data is not available at present in this region thus, our findings can be referenced for the treatment of UTIs in children.

Notes

Acknowledgements

We acknowledge children and their parents/guardians for supporting the study.

Funding

None.

Availability of data and materials

All data generated or analyzed during this study available in the public repository, figshare [ https://doi.org/10.6084/m9.figshare.7359188.v1].

Authors’ contributions

All authors made substantial contributions to the study. RG, BB and DS conceived and designed the study. RG collected sample, investigated and recorded the laboratory findings at the hospital. GR supervised and provided methodology for the study. RG and BB administered the project, reviewed literature, and drafted the manuscript. BB and DS compiled and curated data. DS helped in critical review and revision of the manuscript by compiling, formatting, editing and writing the final version of the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Institutional Review Committee of Shi-Gan International College of Science and Technology (SICOST), Kathmandu, approved this research. Written consent is not feasible for all subjects in Nepalese context since illiteracy is comparatively higher. Thus verbal consent was obtained from parents/guardians on the behalf of their children, as approved by ethical review committee, to omit the selection bias.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.
    Nature, Macmillan Publishers Limited. Urinary tract infection. Available at: https://www.nature.com/subjects/urinary-tract-infection. Accessed 01/02/2016.
  2. 2.
    Minardi D, d’Anzeo G, Cantoro D, Conti A, Muzzonigro G. Urinary tract infections in women: etiology and treatment options. Int J Gen Med. 2011;4:333–43. Full Text.CrossRefGoogle Scholar
  3. 3.
    Rai GK, Upreti HC, Rai SK, Shah KP, Shrestha RM. Causative agents of urinary tract infections in children and their antibiotic sensitivity pattern: a hospital based study. Nepal Med Coll J. 2008;10(2):86–90. Full Text.PubMedGoogle Scholar
  4. 4.
    Nachimuthu R, Chettipalayam S, Velramar B, Kurumandur R, Velu R. Urinary tract infection and antimicrobial susceptibility pattern of extended spectrum beta lactamase producing clinical isolates. Adv Biol Res. 2008;2(5–6):78–82. Full Text.Google Scholar
  5. 5.
    Vandepitte J, Engbaek K, Piot P, Heuck CC, et al. Basic laboratory procedures in clinical bacteriology. 2nd ed. Geneva: World Health Organization; 2003. Full Text.Google Scholar
  6. 6.
    Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW. (ed). Manual of clinical microbiology. 10th ed. American Society of Microbiology; 2011. http://www.asmscience.org/content/book/10.1128/9781555816728.
  7. 7.
    Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing (M100-S25). 25th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2015.Google Scholar
  8. 8.
    Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81. Full Text.CrossRefGoogle Scholar
  9. 9.
    Asokan GV, Vanitha A. Disaster response under one health in the aftermath of Nepal earthquake. J Epidemiol Glob Health 2017;7(1):91–96. [Full Text].Google Scholar
  10. 10.
    Montini G, Tullus, Hewitt I. Febrile urinary tract infections in children. N Engl J Med 2011;365:239–250. [Full Text].CrossRefGoogle Scholar
  11. 11.
    Doern CD, Richardson SE. Diagnosis of urinary tract infections in children. Kraft CS, ed J Clin Microbiol 2016;54(9):2233–2242. [Full Text].Google Scholar
  12. 12.
    Salvatore S, Salvatore S, Cattoni E, Siesto G, Serati M, Sorice P, Torella M. Urinary tract infections in women. Eur J Obstet Gynecol Reprod Biol 2011;156(2):131–136. [Full Text].CrossRefGoogle Scholar
  13. 13.
    De Miranda ÉJP, De Oliveira GSS, Roque FL, Dos Santos SR, Olmos RD, Lotufo PA. Susceptibility to antibiotics in urinary tract infections in a secondary care setting from 2005-2006 and 2010-2011, in São Paulo, Brazil: data from 11,943 urine cultures. Rev Inst Med trop S Paulo. 2014;56:313–24. Full Text.CrossRefGoogle Scholar
  14. 14.
    McLellan LK, Hunstad DA. Urinary tract infection:pathogenesis and outlook. Trends Mol Med. 2016;22(11):946–57. Full Text.CrossRefGoogle Scholar
  15. 15.
    Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis. 2009;49(11):1749–55. Full Text.CrossRefGoogle Scholar
  16. 16.
    Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10):S165–93. Full Text.CrossRefGoogle Scholar

Copyright information

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  1. 1.Department of MicrobiologySiddhi Memorial HospitalBhaktapurNepal
  2. 2.Department of MicrobiologyShi-Gan International College of Science and TechnologyKathmanduNepal
  3. 3.Department of MicrobiologyTri-Chandra Multiple CollegeKathmanduNepal

Personalised recommendations